In the media
News
Partner news
Vor Biopharma Closes $110 Million Series B Financing
Read full storyPartner news
CVRx Raises $50 Million in New Equity Financing
Read full storyIn the media
Investing in innovation – new digital approaches for a new decade
Read full storyPartner news
Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test
Read full storyPartner news
Cue Health Closes $100 Million Series C Financing to Support Launch of Rapid Molecular Testing Platform
Read full storyIn the media
BIO: Is COVID-19 changing how biopharmas think of M&A? Not really, say J&J and Takeda execs
Read full storyIn the media
As Biotech drifts from amyloid hypothesis for Alzheimer’s some see reason to cling on
Read full storyPartner news
HistoSonics Announces $40 Million Financing
Read full storyPartner news
resTORbio and Adicet Bio Announce Merger Agreement to Advance Allogeneic Gamma Delta CAR-T Cell Therapy Technology
Read full storyPartner news
ViaCyte Announces $27 Million Financing to Advance Next Generation Cell Therapies for Diabetes
Read full storyPartner news
Inivata Announces Strategic Collaboration and Investment from NeoGenomics
Read full storyPartner news
Lava Therapeutics Announces Collaboration with Janssen to Develop Bi-specific Gamma-Delta T-cell Engager Therapeutics
Read full storyPartner news
Philogen Announces Options Exercise by Janssen
Read full storyPartner news